Nutritional and Physiologic Significance of Human Milk Proteins1–4

Total Page:16

File Type:pdf, Size:1020Kb

Nutritional and Physiologic Significance of Human Milk Proteins1–4 Nutritional and physiologic significance of human milk proteins1–4 Bo Lönnerdal ABSTRACT NUTRITIONAL ASPECTS OF HUMAN MILK PROTEINS Human milk contains a wide variety of proteins that contribute to The protein content of human milk decreases rapidly during its unique qualities. Many of these proteins are digested and pro- the first month of lactation (1) and declines much more slowly vide a well-balanced source of amino acids to rapidly growing after that. Most proteins are synthesized by the mammary gland, infants. Some proteins, such as bile salt–stimulated lipase, amy- with a few possible exceptions, such as serum albumin (which ␤ ␣ lase, -casein, lactoferrin, haptocorrin, and 1-antitrypsin, assist appears from the maternal circulation). Milk proteins can be clas- in the digestion and utilization of micronutrients and macronutri- sified into 3 groups: mucins, caseins, and whey proteins. Mucins, ents from the milk. Several proteins with antimicrobial activity, also known as milk fat globule membrane proteins, surround the such as immunoglobulins, ␬-casein, lysozyme, lactoferrin, hapto- lipid globules in milk and contribute only a small percentage of corrin, ␣-lactalbumin, and lactoperoxidase, are relatively resist- the total protein content of human milk (2). Because the fat con- ant against proteolysis in the gastrointestinal tract and may, in tent of human milk does not vary during the course of lactation, intact or partially digested form, contribute to the defense of the milk mucin concentration is most likely constant, although breastfed infants against pathogenic bacteria and viruses. Prebi- little information is available concerning this topic. The contents otic activity, such as the promotion of the growth of beneficial of casein and whey proteins, however, change profoundly early in bacteria such as Lactobacilli and Bifidobacteria, may also be pro- lactation; the concentration of whey proteins is very high, vided by human milk proteins. This type of activity can limit the whereas casein is virtually undetectable during the first days of growth of several pathogens by decreasing intestinal pH. Some lactation (3, 4). Subsequently, casein synthesis in the mammary proteins and peptides have immunomodulatory activities (eg, gland and milk casein concentrations increase, whereas the con- cytokines and lactoferrin), whereas others (eg, insulin-like growth centration of total whey proteins decreases, partially because of factor, epidermal growth factor, and lactoferrin) are likely to be an increased volume of milk being produced (Figure 1). As a involved in the development of the intestinal mucosa and other consequence, there is no “fixed” ratio of whey to casein in human organs of newborns. In combination, breast-milk proteins assist milk; it varies throughout lactation (Figure 2). The frequently in providing adequate nutrition to breastfed infants while simul- cited ratio of 60:40 is an approximation of the ratio during the taneously aiding in the defense against infection and facilitating normal course of lactation, but it does vary from Ϸ80:20 in early optimal development of important physiologic functions in new- lactation to 50:50 in late lactation. Because the amino acid com- borns. Am J Clin Nutr 2003;77(suppl):1537S–43S. positions of caseins and whey proteins differ, the amino acid con- tent of human milk also varies during lactation. This is rarely con- KEY WORDS Human milk, breast milk, milk proteins, sidered when estimating requirements. casein, whey proteins, lactoferrin, immunoglobulins, lactoperoxidase, The true protein content of human milk is often overestimated haptocorrin, lysozyme, ␣-lactalbumin because of the high proportion of nonprotein nitrogen (NPN) in human milk (5). The fraction of NPN is low (< 5%) in the milk of most species, which allows a fairly accurate estimation of the true INTRODUCTION milk protein content by total nitrogen analysis. The true milk pro- tein content is estimated by multiplying the nitrogen content of There is no doubt that the proteins in human milk provide an the milk by a dairy protein conversion factor of 6.38, which takes important source of amino acids to rapidly growing breastfed into account such a fraction of NPN. In human milk, however, infants. However, many human milk proteins also play a role in facilitating the digestion and uptake of other nutrients in breast milk. Examples of such proteins are bile salt–stimulated lipase and amylase, which may aid lipid and starch digestion, and 1 From the Departments of Nutrition and Internal Medicine, University of ␤-casein, lactoferrin, and haptocorrin, which may assist in the California, Davis. 2 Presented at the symposium Innovaciones en Fórmulas Infantiles (Inno- absorption of calcium, iron, and vitamin B-12, respectively. vations in Infant Formula), held in Cancun, Mexico, May 23–24, 2002. Human milk proteins also exert numerous physiologic activities, 3 The author’s participation in this symposium was underwritten by Wyeth benefiting breastfed infants in a variety of ways. These activities Nutrition, Philadelphia. include enhancement of immune function, defense against patho- 4 Reprints not available. Address correspondence to B Lönnerdal, Depart- genic bacteria, viruses and yeasts, and development of the gut and ment of Nutrition, University of California, Davis, One Shields Avenue, Davis, its functions. CA 95616. E-mail: [email protected]. Am J Clin Nutr 2003;77(suppl):1537S–43S. Printed in USA. © 2003 American Society for Clinical Nutrition 1537S Downloaded from https://academic.oup.com/ajcn/article-abstract/77/6/1537S/4689886 by guest on 11 January 2018 1538S LÖNNERDAL ᭿ FIGURE 1. Changes in whey protein ( ) and casein ( ) concentrations FIGURE 2. Changes in casein content as a percentage of total protein during lactation in one mother. Data from reference 4. (ie, ratio of whey protein to casein) in 2 mothers during lactation. Data from reference 4. NPN constitutes Ϸ20–25% of total nitrogen, and the use of the nitrogen content and a conversion factor will overestimate milk protein considerably. A more accurate approach is to determine A case could be made that biologically active peptides that are the total nitrogen and NPN contents, subtract the NPN value from formed during the digestion of several human milk proteins, such total nitrogen, and then multiply the value by the conventional as casein phosphopeptides, also represent indigestible protein and Kjeldahl factor of 6.25 (6). This slightly underestimates the total that they should not be included in the total protein content of amino acid equivalents because small peptides and free amino breast milk. However, no such peptides have been detected in the acids are included in the NPN fraction, but this amount is only a stool of breastfed infants, and a likely scenario is that they are few percent of the total. It is, of course, possible to determine the transiently formed during digestion in the upper gastrointestinal precise amino acid content and the true protein content ( amino tract. It is possible that they may be formed in the duodenum or nitrogen) by amino acid analysis, but this procedure is expensive upper jejunum to exert their physiologic activity locally, to sub- and time-consuming. True protein contents determined with the sequently be completely digested and absorbed in the lower use of the “corrected Kjeldahl” method and amino acid analysis jejunum and ileum. Further experimental evidence is needed to have been shown to agree closely (6). support this scenario. The true protein content of breast milk, determined as described above, is 14–16 g/L during early lactation, 8–10 g/L at 3–4 mo of lactation, and 7–8 g/L at 6 mo and later (1, 4). It has been argued ROLE OF HUMAN MILK PROTEINS IN NUTRIENT that these protein concentrations and, consequently, the corre- ABSORPTION sponding intakes do not accurately reflect the utilizable amounts It is well known that nutrients are utilized exceptionally well of amino acids provided to breastfed infants. This argument is from breast milk. Several factors likely contribute to this high based on the observation that intact breast-milk proteins can be degree of utilization, and some of these factors may be proteins found in the stool of breastfed infants; thus, they are incompletely present in human milk. There are proteins that bind essential nutri- digested and do not represent utilizable amino acids (7). It has ents, help keep them in solution, and facilitate their uptake by the therefore been suggested that such proteins [eg, lactoferrin and intestinal mucosa. Other proteins (protease inhibitors) may assist secretory immunoglobulin A (sIgA)] should be subtracted from in this process by limiting the activity of proteolytic enzymes, the protein concentration of breast milk to derive a true digestible thereby preserving the physiologic function of some relatively sta- protein content. However, it is not correct to assume that these ble binding proteins. Furthermore, some enzymes can affect the proteins are completely indigestible, even if they have properties digestion and utilization of macronutrients. that make them more resistant to proteolytic enzymes than are most other proteins. It is only a minor fraction that escapes diges- Activities related to digestive function tion; for example, it has been estimated that 6–10% of lactoferrin Bile salt–stimulated lipase is not digested by breastfed infants (7). The quantitatively most significant of the relatively indigestible human milk proteins are The presence of bile salt–stimulated lipase in human milk may lactoferrin and sIgA. The total concentration of these 2 proteins aid in the digestion of lipids in newborns, particularly in preterm in mature milk (> 30 d of lactation) is Ϸ2 g/L; assuming that infants, who have low lipase activity and poor lipid utilization 6–10% is undigested, there is a potential loss of Ϸ0.12–0.2 g/L (8, 9). It has been shown that the heating of breast milk, which (or Ϸ1.2–2.0% of total protein intake), which may be within the destroys the activity of bile salt–stimulated lipase, results in margin of error for the analysis used.
Recommended publications
  • Mary Bartlett Bunge 40
    EDITORIAL ADVISORY COMMITTEE Marina Bentivoglio Larry F. Cahill Stanley Finger Duane E. Haines Louise H. Marshall Thomas A. Woolsey Larry R. Squire (Chairperson) The History of Neuroscience in Autobiography VOLUME 4 Edited by Larry R. Squire ELSEVIER ACADEMIC PRESS Amsterdam Boston Heidelberg London New York Oxford Paris San Diego San Francisco Singapore Sydney Tokyo This book is printed on acid-free paper. (~ Copyright 9 byThe Society for Neuroscience All Rights Reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. Permissions may be sought directly from Elsevier's Science & Technology Rights Department in Oxford, UK: phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: [email protected]. You may also complete your request on-line via the Elsevier homepage (http://elsevier.com), by selecting "Customer Support" and then "Obtaining Permissions." Academic Press An imprint of Elsevier 525 B Street, Suite 1900, San Diego, California 92101-4495, USA http ://www.academicpress.com Academic Press 84 Theobald's Road, London WC 1X 8RR, UK http://www.academicpress.com Library of Congress Catalog Card Number: 2003 111249 International Standard Book Number: 0-12-660246-8 PRINTED IN THE UNITED STATES OF AMERICA 04 05 06 07 08 9 8 7 6 5 4 3 2 1 Contents Per Andersen 2 Mary Bartlett Bunge 40 Jan Bures 74 Jean Pierre G. Changeux 116 William Maxwell (Max) Cowan 144 John E. Dowling 210 Oleh Hornykiewicz 240 Andrew F.
    [Show full text]
  • The Two Faces of Thrombosis: Coagulation Cascade and Platelet Aggregation. Are Platelets the Main Therapeutic Target
    Thrombosis and Circulation Open Access Cimmino et al., J Thrombo Cir 2017, 3:1 Review Article Open Access The Two Faces of Thrombosis: Coagulation Cascade and Platelet Aggregation. Are Platelets the Main Therapeutic Target? Giovanni Cimmino*, Salvatore Fischetti and Paolo Golino Department of Cardio-Thoracic and Respiratory Sciences, Section of Cardiology, University of Campania “Luigi Vanvitelli”, Naples, Italy *Corresponding author: Giovanni Cimmino, MD, PhD, Department of Cardio-Thoracic and Respiratory Sciences, Section of Cardiology, University of Campania “Luigi Vanvitelli”, via Leonardo Bianchi, 180131 Naples, Italy. Tel: +39-081-7064175, Fax: +39-081-7064234; E-mail: [email protected] Received date: Dec 28, 2016, Accepted date: Jan 27, 2017, Published date: Jan 31, 2017 Copyright: © 2017 Giovanni C, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Acute thrombus formation is the pathophysiological substrate underlying several clinical conditions, such as acute coronary syndrome (ACS) and stroke. Activation of coagulation cascade is a key step of the thrombotic process: vessel injury results in exposure of the glycoprotein tissue factor (TF) to the flowing blood. Once exposed, TF binds factor VII/VIIa (FVII/FVIIa) and in presence of calcium ions, it forms a tertiary complex able to activate FX to FXa, FIX to FIXa, and FVIIa itself. The final step is thrombin formation at the site of vessel injury with subsequent platelet activation, fibrinogen to fibrin conversion and ultimately thrombus formation. Platelets are the key cells in primary hemostasis.
    [Show full text]
  • Diagnostic Methods in Hematology II
    DiagnosticDiagnostic methodsmethods inin hematologyhematology IIII Jan Zivny Department of Pathophysiology 1. LF UK OutlineOutline Specialized hematology tests • Evaluation of anemia – Anemia basics • Anemia caused by excessive erythrocyte loss • Anemia caused by deficient erythropoiesis • Diagnostic methods used in leukemia/lymphoma ANEMIAANEMIA • WHO criteria: Hb < 125 g/L in adults • US criteria: –M: Hb < 135 g/L –F: Hb < 125 g/L •• AnemiaAnemia isis clinicalclinical signsign CausesCauses ofof anemiaanemia • Insufficient RBC production – deficient erythropoiesis • Excessive RBC loss – Hemolysis (shortened lifespan of erythrocytes) – Acute bleeding (chronic bleeding leads to iron depletion and results in iron loss and deficient erythropoiesis) AnemiaAnemia causedcaused byby deficientdeficient erythropoiesiserythropoiesis Causes of insufficient erythropoiesis? AnemiaAnemia causedcaused byby deficientdeficient erythropoiesiserythropoiesis • Iron metabolism related (microcytic) – Iron deficiency – Chronic diseases • Vitamin B12 or folate deficiency (macrocytic) • Insuficient EPO production and marrow failure (normocytic) – kidney failure – aplastic anemia – myelodysplasia – leukemia DiagnosticDiagnostic aproachesaproaches toto ironiron metabolismmetabolism relatedrelated anemiaanemia IronIron deficiencydeficiency ChronicChronic diseasesdiseases IronIron deficiencydeficiency • microcytic anemia and/or anisocytosis • ↓ blood reticulocytes • hypoproliferative BM • Blood loss in excess of 10 to 20 mL of blood per day (> 5-10 mg of iron) or
    [Show full text]
  • Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed.
    [Show full text]
  • Intrinsic Factor
    ENZYMES INTRINSIC FACTOR EINECS Number 232-711-9 Alternative Names Vitamin B12-binding protein, Factor VII, Intrinsic Factor protein Assay Principle Intrinsic Factor binds specifically to Vitamin B12. The coating of a Vitamin B12-BSA (IF Content) conjugate to the ELISA plate allows for the extent of Intrinsic Factor binding to be investigated. A Mouse monoclonal Anti-Intrinsic Factor antibody is used to identify the concentration of Intrinsic Factor bound to the Vitamin B12. The Antibody bound to the Intrinsic Factor on the plate is identified by use of an Anti Mouse AP conjugate. PNPP substrate is used to develop signals, read at an absorbance of 405nm on a plate reader. What is pernicious anaemia? Key Benefits Intrinsic Factor is primarily used in the diagnosis of pernicious anaemia, a condition caused by a vitamin B12 deficiency. Prevalence in the general + SUPPLY SECURITY population varies from around 3% - 5%, and increases dramatically to Fully manufactured by BBI 5% - 20% among people older than 65 years. Solutions at our Crumlin site, ensuring control over manufacturing processes and supply chain + HIGH PURITY Intrinsic Factor has a purity of >95% ensuring optimal performance in your assay + PROVEN PERFORMANCE Porcine Intrinsic Factor works in a range of immunoassay formats The role of Intrinsic Factor in diagnosis + HIGH QUALITY Intrinsic Factor has a high affinity and specificity to vitamin B12, which Manufactured under a makes it ideal for use in immunoassays. Most commercial assays utilise Quality System compliant a competitive binding technique generating a chemiluminescent signal. with ISO 13485:2016 with Commercial assays can usually detect to a level of ~50 pg/ml vitamin B12.
    [Show full text]
  • In Vitro Modelling of the Mucosa of the Oesophagus and Upper Digestive Tract
    21 Review Article Page 1 of 21 In vitro modelling of the mucosa of the oesophagus and upper digestive tract Kyle Stanforth1, Peter Chater1, Iain Brownlee2, Matthew Wilcox1, Chris Ward1, Jeffrey Pearson1 1NUBI, Newcastle University, Newcastle upon Tyne, UK; 2Applied Sciences (Department), Northumbria University, Newcastle upon Tyne, UK Contributions: (I) Conception and design: All Authors; (II) Administrative support: All Authors; (III) Provision of study materials or patients: All Authors; (IV) Collection and assembly of data: All Authors; (V) Data analysis and interpretation: All Authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Kyle Stanforth. NUBI, Medical School, Framlington Place, Newcastle University, NE2 4HH, Newcastle upon Tyne, UK. Email: [email protected]. Abstract: This review discusses the utility and limitations of model gut systems in accurately modelling the mucosa of the digestive tract from both an anatomical and functional perspective, with a particular focus on the oesophagus and the upper digestive tract, and what this means for effective in vitro modelling of oesophageal pathology. Disorders of the oesophagus include heartburn, dysphagia, eosinophilic oesophagitis, achalasia, oesophageal spasm and gastroesophageal reflux disease. 3D in vitro models of the oesophagus, such as organotypic 3D culture and spheroid culture, have been shown to be effective tools for investigating oesophageal pathology. However, these models are not integrated with modelling of the upper digestive tract—presenting an opportunity for future development. Reflux of upper gastrointestinal contents is a major contributor to oesophageal pathologies like gastroesophageal reflux disease and Barratt’s oesophagus, and in vitro models are essential for understanding their mechanisms and developing solutions.
    [Show full text]
  • Hereditary Intrinsic Factor Deficiency in China Caused by a Novel Mutation
    Ruan et al. BMC Medical Genetics (2020) 21:221 https://doi.org/10.1186/s12881-020-01158-z CASE REPORT Open Access Hereditary intrinsic factor deficiency in China caused by a novel mutation in the intrinsic factor gene—a case report Jing Ruan, Bing Han* , Junling Zhuang, Miao Chen, Fangfei Chen, Yuzhou Huang and Wenzhe Zhou Abstract Background: Hereditary intrinsic factor deficiency is a rare disease characterized by cobalamin deficiency with the lack of gastric intrinsic factor because of gastric intrinsic factor (GIF) mutations. Patients usually present with cobalamin deficiency without gastroscopy abnormality and intrinsic factor antibodies. Case presentation: A Chinese patient presented with recurrent severe anemia since age 2 with low cobalamin level and a mild elevation of indirect bilirubin. The hemoglobin level normalized each time after intramuscular vitamin B12 injection. Gene test verified a c.776delA frame shift mutation in exon 6 combined with c.585C > A nonsense early terminationmutationinexon5ofGIF which result in the dysfunction of gastric intrinsic factor protein. The hereditary intrinsic factor deficiency in literature was further reviewed and the ancestry of different mutation sites were discussed. Conclusions: A novel compound heterozygous mutation of GIF in a Chinese patient of hereditary intrinsic factor deficiency was reported. It was the first identified mutation of GIF in East-Asia and may indicate a new ancestry. Keywords: Megaloblastic anemia, Cobalamin deficiency, Intrinsic factor Background IFD is caused by homozygous or compound heterozy- Vitamin B12 or cobalamin deficiency is characterized by gous mutation in the gene of gastric intrinsic factor on megaloblastic anemia with neurological problems and chromosome 11q12. It presents in early childhood with can be caused by numerous acquired and inherited dis- the lack of gastric intrinsic factor, while the gastric acid eases [1].
    [Show full text]
  • Vitamin B12) Deficiency in Johanson–Blizzard Syndrome
    European Journal of Clinical Nutrition (2013) 67, 1118 & 2013 Macmillan Publishers Limited All rights reserved 0954-3007/13 www.nature.com/ejcn LETTER TO THE EDITOR Pancytopenia from severe cobalamin (Vitamin B12) deficiency in Johanson–Blizzard syndrome European Journal of Clinical Nutrition (2013) 67, 1118; doi:10.1038/ insufficiency and villous atrophy.3 Defective absorption of ejcn.2013.140; published online 31 July 2013 cobalamin may occur in 40–50% of patients with pancreatic insufficiency,5 exact mechanism(s) remain unclear. Proteolytic degradation of non-intrinsic factor-cobalamin binders has been proposed as the pancreas’ primary role in cobalamin metabolism.6 Johanson–Blizzard syndrome is a rare autosomal recessive Additional studies suggest that adequate bicarbonate is necessary disorder characterized by nasal, auditory and dental abnormalities, for pancreatic proteases to function in the intestinal lumen, and 1 there may be interaction between pancreatic enzymes and bile, and exocrine pancreatic insufficiency. These patients require 5 oral pancreatic enzyme replacement and fat-soluble vitamin affecting R binder degradation and cobalamin absorption. supplements.2 In Johanson–Blizzard syndrome, however, ductular output of fluid and electrolytes is preserved.2 Cobalamin (vitamin B12) is essential for several important enzymatic processes in the body that lead to energy metabolism, As patients with exocrine pancreatic insufficiency are on DNA synthesis and blood cell production. Patients with cobalamin fat-soluble vitamin (A,D, E,K) supplements because of steatorrhea deficiency can develop hematological and neuropsychiatric and risk of malabsorption of these vitamins, the clinicians focus on abnormalities. Absorption of cobalamin is complex. Two distinct monitoring the status of these four vitamins.
    [Show full text]
  • Blood Coagulation Overview and Inherited Hemorrhagic Disorders 2002 Abshire
    Blood Coagulation Overview and Inherited Hemorrhagic Disorders 2002 Abshire 1) Thrombin is one of the key proteins in the coagulation cascade and has both procoagulant and anticoagulant properties. Which one of the following is an important anticoagulation function: a. Activation of factors V and VIII b. Factor XIII activation c. Stimulation of the thrombin activated fibrinolytic inhibitor (TAFI) d. Complex with thrombomodulin (TM). 2) The endothelial cell lining blood vessels possesses several important anticoagulation functions . Which one of the following is one of its' important hemostasis (procoagulant) functions? a. Production of nitric oxide (NO) b. Activation of thrombomodulin (TM) c. Release of plasminogen activator inhibitor (PAI-I) d. Release of TPA e. Interaction of heparin sulfate with anti-thrombin III (AT III) 3) A term well infant is born without complications after a normal pregnancy and initial nursery stay. Upon drawing the metabolic screen, the baby is noted to have prolonged oozing from the heelstick sample. CBC, plt ct, PT, a PTT and fibrinogen were normal. Family history is negative. He returns for the 2 week check and the mother notices that the umbilical cord has been oozing for 4 days. A screening test for factor XIII deficiency is ordered and the baby's clot does not dissolve in 5 M urea. The euglobulin lysis time (ELT) was less than one hour. The most likely diagnosis is: a. Factor XIII heterozygous deficiency b. Homozygous antiplasmin deficiency c. Mild hemophilia B (Factor IX deficiency) d. von Willebrand Disease e. Tissue plasminogen activator (TPA) excess. 4) The newborn's coagulation system is both similar and quite different from a child's.
    [Show full text]
  • General Considerations of Coagulation Proteins
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 2 Copyright © 1978, Institute for Clinical Science General Considerations of Coagulation Proteins DAVID GREEN, M.D., Ph.D.* Atherosclerosis Program, Rehabilitation Institute of Chicago, Section of Hematology, Department of Medicine, and Northwestern University Medical School, Chicago, IL 60611. ABSTRACT The coagulation system is part of the continuum of host response to injury and is thus intimately involved with the kinin, complement and fibrinolytic systems. In fact, as these multiple interrelationships have un­ folded, it has become difficult to define components as belonging to just one system. With this limitation in mind, an attempt has been made to present the biochemistry and physiology of those factors which appear to have a dominant role in the coagulation system. Coagulation proteins in general are single chain glycoprotein molecules. The reactions which lead to their activation are usually dependent on the presence of an appropriate surface, which often is a phospholipid micelle. Large molecular weight cofactors are bound to the surface, frequently by calcium, and act to induce a favorable conformational change in the reacting molecules. These mole­ cules are typically serine proteases which remove small peptides from the clotting factors, converting the single chain species to two chain molecules with active site exposed. The sequence of activation is defined by the enzymes and substrates involved and eventuates in fibrin formation. Mul­ tiple alternative pathways and control mechanisms exist throughout the normal sequence to limit coagulation to the area of injury and to prevent interference with the systemic circulation. Introduction RatnofP4 eloquently indicates in an arti­ cle aptly entitled: “A Tangled Web.
    [Show full text]
  • The Path to an Orally Administered Protein Therapeutic for the Treatment of Diabetes Mellitus
    Syracuse University SURFACE Chemistry - Dissertations College of Arts and Sciences 12-2012 The Path to an Orally Administered Protein Therapeutic for the Treatment of Diabetes Mellitus Susan Clardy James Syracuse University Follow this and additional works at: https://surface.syr.edu/che_etd Part of the Chemistry Commons Recommended Citation James, Susan Clardy, "The Path to an Orally Administered Protein Therapeutic for the Treatment of Diabetes Mellitus" (2012). Chemistry - Dissertations. 196. https://surface.syr.edu/che_etd/196 This Dissertation is brought to you for free and open access by the College of Arts and Sciences at SURFACE. It has been accepted for inclusion in Chemistry - Dissertations by an authorized administrator of SURFACE. For more information, please contact [email protected]. Abstract Protein therapeutics like insulin and glucagon-like peptide-1 analogues are currently used as injectable medications for the treatment of diabetes mellitus. An orally administered protein therapeutic is predicted to increase patient adherence to medication and bring a patient closer to metabolic norms through direct effects on hepatic glucose production. The major problem facing oral delivery of protein therapeutics is gastrointestinal tract hydrolysis/proteolysis and the inability to passage the enterocyte. Herein we report the potential use of vitamin B12 for the oral delivery of protein therapeutics. We first investigated the ability of insulin to accommodate the attachment of B12 at the B1 vs. B29 amino acid position. The insulinotropic profile of both conjugates was evaluated in streptozotocin induced diabetic rats. Oral administration of the conjugates produced significant drops in blood glucose levels, compared to an orally administered insulin control, but no significant difference was observed between conjugates.
    [Show full text]
  • Vitamin B12 Deficiency Cascade: Understanding Nutritional Deficit
    Vitamin B12 Deficiency Cascade: Understanding Nutritional Deficit In the United States and the United Kingdom, vitamin B12 and/or complete blood count (CBC) values suggestive of B12 deficiency is estimated to affect about 6% of people below age deficiency.10 Although often used as the first-line screening test 60 and nearly 20% above age 60.1 for B12 deficiency, serum B12 measurement used in isolation generally has poor sensitivity and specificity for detection of B12 Vitamin B12 is an essential nutrient for the production of deficiency, causing a significant number of patients with vitamin normal red blood cells, DNA synthesis, and normal neurological B12 deficiency to be overlooked.11 function.2 Low B12 status is rarely attributable to dietary insufficiency and is more typically the result of malabsorption LabCorp’s Vitamin B12 Deficiency Cascade (141503) utilizes a related to chronic inflammation of the stomach or the use of sequential selection algorithm to properly identify patients with medications such as proton pump inhibitors and metformin.3,4 vitamin B12 deficiency and to understanding the cause of the One of the most common causes of vitamin B12 deficiency nutritional deficit, such as Pernicious Anemia (see algorithm on is a condition known as Pernicious Anemia (PA), a type of the reverse). In this approach, a second-line assay, Methylmalonic autoimmune-mediated chronic atrophic gastritis.5,6 Patients with Acid (MMA), Serum or Plasma (706961), is performed when the PA lack intrinsic factor proteins, which are essential for
    [Show full text]